Day One Biopharmaceuticals (DAWN) Free Cash Flow (2020 - 2025)
Day One Biopharmaceuticals (DAWN) free cash flow from Jun 30, 2020 to Dec 31, 2025. The TTM Day One Biopharmaceuticals (DAWN) free cash flow is -$104M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Day One Biopharmaceuticals (DAWN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +29.63% |
| 3 Years TTM | -1.80% |
| 5 Years TTM | +68.60% |
| All Time TTM | +35.23% |
Annual Free Cash Flow change of Day One Biopharmaceuticals (DAWN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$104M | +29.65% |
| 2024 | -$80M | -45.41% |
| 2023 | -$147M | +33.82% |
| 2022 | -$110M | +126.41% |
| 2021 | -$49M | +257.44% |
| 2020 | -$14M | +201.11% |
| 2019 | -$4.51M | N/A |